Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
Headache: The Journal of Head and Face Pain · 2024-07 · 64 (7) · 849-858
DOI: 10.1111/head.14768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 24.06.2024. Verfasst von Marta Pascual-Mato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqué…. Hauptthemen laut MEDLINE: Migraine Disorders, Inflammatory Bowel Diseases, Comorbidity, Calcitonin Gene-Related Peptide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Objective
To analyze the specificity of calcitonin gene–related peptide (CGRP) levels, we measured alpha‐CGRP circulating levels in a large series of patients with a recent diagnosis of inflammatory bowel disease (IBD) who were interviewed regarding comorbid headache.
Background
Several studies have found an association between migraine and IBD.
Methods
In this cross‐sectional study performed in an IBD clinic, morning serum alpha‐CGRP levels were measured by enzyme‐linked immunosorbent assay in 96 patients who were recently diagnosed with IBD and compared to those from 50 similar patients with chronic migraine (CM) and 50 healthy controls (HC).
Results
Alpha‐CGRP levels were higher in patients with IBD (median [interquartile range] 56.9 [35.6–73.9] pg/mL) and patients with CM (53.0 [36.7–73.9] pg/mL) compared to HC (37.2 [30.0–51.8] pg/mL; p = 0.003; p = 0.019, respectively). Regarding IBD diagnostic subtypes, alpha‐CGRP levels for ulcerative colitis (67.2 ± 49.3 pg/mL; 57.0 [35.6–73.4] pg/mL) and Crohn's disease (54.9 ± 27.5 pg/mL; 57.7 [29.1–76.1] pg/mL) were significantly higher than those of HC ( p = 0.013, p = 0.040, respectively). Alpha‐CGRP levels were further different in patients with IBD with migraine (70.9 [51.8–88.7] pg/mL) compared to HC ( p < 0.001), patients with IBD without headache (57.5 [33.3–73.8] pg/mL; p = 0.049), and patients with IBD with tension‐type headache but without migraine (41.7 [28.5–66.9] pg/mL; p = 0.004), though alpha‐CGRP levels in patients with IBD without migraine (53.7 [32.9–73.5] pg/mL) remained different over HC ( p = 0.028).
Conclusion
Together with CM, circulating alpha‐CGRP levels are different in patients with IBD, perhaps reflecting a chronic inflammatory state. IBD is an example of how alpha‐CGRP levels are not a totally specific migraine biomarker. However, alpha‐CGRP levels were further increased in patients with IBD who have a history of migraine, which reinforces its role as a biomarker in migraine patients, always bearing in mind their comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.
- Service of Neurology, University Hospital Marqués de Valdecilla, Universidad de Cantabria and IDIVAL, Santander, Spain.
ORCID-Profile: Marta Pascual-Mato, Gabriel Gárate, Javier Crespo, Julio Pascual
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Pascual-Mato, M., Gárate, G., González-Quintanilla, V., Madera-Fernández, J., Castro, B., García, M. J., Crespo, J., Rivero, M., & Pascual, J. (2024). Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study. Headache: The Journal of Head and Face Pain, 64(7), 849-858. https://doi.org/10.1111/head.14768
Vancouver
Pascual-Mato M, Gárate G, González-Quintanilla V, Madera-Fernández J, Castro B, García MJ, et al. Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study. Headache: The Journal of Head and Face Pain. 2024;64(7):849-858. doi:10.1111/head.14768
BibTeX
@article{PascualMato2024,
author = {Pascual-Mato, Marta and Gárate, Gabriel and González-Quintanilla, Vicente and Madera-Fernández, Jorge and Castro, Beatriz and García, María José and Crespo, Javier and Rivero, Montserrat and Pascual, Julio},
title = {Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study},
journal = {Headache: The Journal of Head and Face Pain},
year = {2024},
volume = {64},
number = {7},
pages = {849--858},
doi = {10.1111/head.14768}
}
EUVIMED